ASTS
AST SpaceMobile, Inc.
ASTS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
LSAK
Lesaka Technologies, Inc.
LSAK has the edge over ASTS overall, supported by lower modeled downside and stronger fundamentals.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LSAK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
LSAK's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
LSAK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 111x | $3.32 | — |
| Cheap | 125x | $3.75 | +13% |
| Fair | 140x | $4.19 | +26% |
| Expensive | 146x | $4.39 | +32% |
Historical ranges are pointers, not guarantees.
LSAK's PE is 111x, but its earnings don't support one, so it isn't a reliable read right now.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
LSAK Forward outlook
There aren't enough analyst estimates for LSAK to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
LSAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.03 | +$1.15 |
| Q2 2026 | $0.03 | +$1.17 |
| Q1 2026 | -$0.40 | +$0.42 |
| Q4 2025 | -$0.68 | -$0.07 |
| Q3 2025 | -$1.12 | -$0.87 |
| Q2 2025 | -$1.14 | -$0.87 |
| Q3 2022 | -$0.69 | -$0.30 |
| Q2 2022 | -$0.75 | -$0.08 |
LSAK has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
LSAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $184.6M | +7.7% |
| Q2 2026 | $188.3M | +12% |
| Q1 2026 | $183.1M | +13% |
| Q4 2025 | $178.7M | +1.4% |
| Q3 2025 | $171.4M | +12% |
| Q2 2025 | $168.5M | +15% |
| Q1 2025 | $161.5M | +17% |
| Q4 2024 | $176.2M | +22% |
LSAK's revenue has grown year over year for 19 quarters in a row: $185M last quarter, up 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.6% | -0.8 points |
| Q2 2026 | 3.4% | +20 points |
| Q1 2026 | 2.2% | +1.9 points |
| Q4 2025 | 1.2% | +0.8 points |
| Q3 2025 | 0.2% | +0.3 points |
| Q2 2025 | -17% | -17 points |
| Q1 2025 | 0.3% | -0.2 points |
| Q4 2024 | 0.4% | -1.1 points |
LSAK has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
LSAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15M | -404% |
| Q2 2026 | $7.5M | +$18.1M |
| Q1 2026 | $34.2M | +336% |
| Q4 2025 | -$14.8M | +$646K |
| Q3 2025 | $4.9M | +$13M |
| Q2 2025 | -$10.6M | -1229% |
| Q1 2025 | $7.8M | -52% |
| Q4 2024 | -$15.5M | -$13.9M |
LSAK has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
LSAK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +198K shares |
| 1 year | +1.7% | +1.3M shares |
| 3 years | +39% | +22.5M shares |
LSAK has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $186,000 |
| Q2 2026 | $28,000 |
| Q1 2026 | $40,000 |
| Q4 2025 | $271,000 |
| Q2 2025 | $1M |
| Q1 2025 | $27,000 |
| Q4 2024 | $12.6M |
| Q2 2024 | $1.3M |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LSAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 7.2x | High |
| Q3 2025 | 10.0x | High |
| Q2 2025 | 18.8x | High |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 3.1x | Elevated |
LSAK's net debt is about 2.3 years of its operating earnings (EBITDA), down from 10 years a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
LSAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.8 | Oversold |
| Stochastic | 5.2 | Oversold |
LSAK's weekly RSI is 28 (oversold) and its Stochastic is 5 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
LSAK PE vs Technology Sector
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over LSAK on trend strength, trading above more of its moving averages.
LSAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.07 | 18% below |
| 20 week MA | $4.40 | 25% below |
| 50 week MA | $4.58 | 28% below |
| 100 week MA | $4.56 | 27% below |
| 200 week MA | $4.39 | 24% below |
LSAK is in a downtrend: it's below all five of its weekly moving averages, and 24% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
LSAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.74 | $4.74 | +27% |
| 2021 | $4.74 | $5.41 | +14% |
| 2022 | $5.41 | $3.79 | -30% |
| 2023 | $3.79 | $3.24 | -15% |
| 2024 | $3.24 | $5.25 | +62% |
| 2025 | $5.25 | $4.36 | -17% |
| 2026 YTD | $4.36 | $3.32 | -24% |
LSAK has the edge over ASTS on returns for 2026, with the stronger performance.